Identification of Fused-Ring Alkanoic Acids with Improved Pharmacokinetic Profiles that Act as G Protein-Coupled Receptor 40/Free Fatty Acid Receptor 1 Agonists

Citations Over TimeTop 10% of 2012 papers

Abstract

The G protein-coupled receptor 40 (GPR40)/free fatty acid receptor 1 (FFA1) has emerged as an attractive target for a novel insulin secretagogue with glucose dependency. We previously identified phenylpropanoic acid derivative 1 (3-{4-[(2',6'-dimethylbiphenyl-3-yl)methoxy]-2-fluorophenyl}propanoic acid) as a potent and orally available GPR40/FFA1 agonist; however, 1 exhibited high clearance and low oral bioavailability, which was likely due to its susceptibility to β-oxidation at the phenylpropanoic acid moiety. To identify long-acting compounds, we attempted to block the metabolically labile sites at the phenylpropanoic acid moiety by introducing a fused-ring structure. Various fused-ring alkanoic acids with potent GPR40/FFA1 activities and good PK profiles were produced. Further optimizations of the lipophilic portion and the acidic moiety led to the discovery of dihydrobenzofuran derivative 53 ((6-{[4'-(2-ethoxyethoxy)-2',6'-dimethylbiphenyl-3-yl]methoxy}-2,3-dihydro-1-benzofuran-3-yl)acetic acid), which acted as a GPR40/FFA1 agonist with in vivo efficacy during an oral glucose tolerance test (OGTT) in rats with impaired glucose tolerance.

Related Papers

• → The G-Protein-Coupled Long-Chain Fatty Acid Receptor GPR40 and Glucose Metabolism(2014)45 cited
• → Solid–liquid equilibria in the acetic acid–propanoic acid and propanoic acid–trifluoroacetic acid systems(1999)20 cited
• → Synthesis Propyl Propanoic from Propanoic Acid by Esterification Reaction(2017)1 cited
• → Convenient Syntheses of Racemic 2-(3-Nitrophenyl)propanoic Acid and 2-(3-Aminophenyl)propanoic Acid(1997)1 cited
• Progress in free fatty acid receptor GPR40(2005)